Study to evaluate the diagnostic efficacy of Gd-EOB-DTPA in the characterization of focal liver lesions
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
A multi-center (US) open-label study of Gd-EOB-DTPA with a single intravenous injection (25 μmol/kg body weight) in patients with known or suspected focal liver lesions and the corresponding blinded reading to evaluate the diagnostic efficacy of Gd-EOB-DTPA in the characterization of focal liver lesions